vs

Side-by-side financial comparison of F5, Inc. (FFIV) and Genius Sports Ltd (GENI). Click either name above to swap in a different company.

F5, Inc. is the larger business by last-quarter revenue ($811.7M vs $510.9M, roughly 1.6× Genius Sports Ltd). F5, Inc. runs the higher net margin — 18.2% vs -12.3%, a 30.6% gap on every dollar of revenue. Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 8.0%).

F5, Inc. is an American technology company specializing in application security, multi-cloud management, online fraud prevention, application delivery networking (ADN), application availability and performance, and network security, access, and authorization.

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

FFIV vs GENI — Head-to-Head

Bigger by revenue
FFIV
FFIV
1.6× larger
FFIV
$811.7M
$510.9M
GENI
Higher net margin
FFIV
FFIV
30.6% more per $
FFIV
18.2%
-12.3%
GENI
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
8.0%
FFIV

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
FFIV
FFIV
GENI
GENI
Revenue
$811.7M
$510.9M
Net Profit
$148.0M
$-63.0M
Gross Margin
81.4%
25.2%
Operating Margin
22.1%
-11.5%
Net Margin
18.2%
-12.3%
Revenue YoY
11.0%
Net Profit YoY
1.5%
EPS (diluted)
$2.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FFIV
FFIV
GENI
GENI
Q1 26
$811.7M
Q4 25
$822.5M
$510.9M
Q3 25
$810.1M
$335.4M
Q2 25
$780.4M
$215.2M
Q1 25
$731.1M
$119.7M
Q4 24
$766.5M
$413.0M
Q3 24
$746.7M
$285.8M
Q2 24
$695.5M
$184.1M
Net Profit
FFIV
FFIV
GENI
GENI
Q1 26
$148.0M
Q4 25
$180.1M
$-63.0M
Q3 25
$190.5M
Q2 25
$189.9M
$-47.3M
Q1 25
$145.5M
$-25.5M
Q4 24
$166.4M
$-85.5M
Q3 24
$165.3M
$-47.1M
Q2 24
$144.1M
$-35.5M
Gross Margin
FFIV
FFIV
GENI
GENI
Q1 26
81.4%
Q4 25
81.5%
25.2%
Q3 25
82.2%
24.2%
Q2 25
81.0%
19.1%
Q1 25
80.7%
10.7%
Q4 24
81.7%
16.7%
Q3 24
80.8%
20.5%
Q2 24
80.4%
18.6%
Operating Margin
FFIV
FFIV
GENI
GENI
Q1 26
22.1%
Q4 25
26.0%
-11.5%
Q3 25
25.4%
-15.3%
Q2 25
25.2%
-21.0%
Q1 25
21.7%
-20.3%
Q4 24
26.8%
-18.0%
Q3 24
25.6%
-13.9%
Q2 24
23.4%
-16.8%
Net Margin
FFIV
FFIV
GENI
GENI
Q1 26
18.2%
Q4 25
21.9%
-12.3%
Q3 25
23.5%
Q2 25
24.3%
-22.0%
Q1 25
19.9%
-21.3%
Q4 24
21.7%
-20.7%
Q3 24
22.1%
-16.5%
Q2 24
20.7%
-19.3%
EPS (diluted)
FFIV
FFIV
GENI
GENI
Q1 26
$2.58
Q4 25
$3.10
Q3 25
$3.25
Q2 25
$3.25
Q1 25
$2.48
Q4 24
$2.82
Q3 24
$2.79
Q2 24
$2.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FFIV
FFIV
GENI
GENI
Cash + ST InvestmentsLiquidity on hand
$1.4B
$280.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$3.6B
$724.5M
Total Assets
$6.5B
$1.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FFIV
FFIV
GENI
GENI
Q1 26
$1.4B
Q4 25
$1.2B
$280.6M
Q3 25
$1.3B
$110.2M
Q2 25
$1.4B
$110.2M
Q1 25
$1.3B
$110.2M
Q4 24
$1.2B
$100.3M
Q3 24
$1.1B
$100.3M
Q2 24
$935.6M
$100.3M
Stockholders' Equity
FFIV
FFIV
GENI
GENI
Q1 26
$3.6B
Q4 25
$3.5B
$724.5M
Q3 25
$3.6B
$572.4M
Q2 25
$3.5B
$572.4M
Q1 25
$3.3B
$572.4M
Q4 24
$3.2B
$573.0M
Q3 24
$3.1B
$573.0M
Q2 24
$3.0B
$573.0M
Total Assets
FFIV
FFIV
GENI
GENI
Q1 26
$6.5B
Q4 25
$6.3B
$1.1B
Q3 25
$6.3B
$792.3M
Q2 25
$6.1B
$792.3M
Q1 25
$5.9B
$792.3M
Q4 24
$5.9B
$775.7M
Q3 24
$5.6B
$775.7M
Q2 24
$5.4B
$775.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FFIV
FFIV
GENI
GENI
Operating Cash FlowLast quarter
$525.1M
$81.9M
Free Cash FlowOCF − Capex
$69.6M
FCF MarginFCF / Revenue
13.6%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
3.55×
TTM Free Cash FlowTrailing 4 quarters
$33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FFIV
FFIV
GENI
GENI
Q1 26
$525.1M
Q4 25
$159.2M
$81.9M
Q3 25
$208.1M
$-4.8M
Q2 25
$282.2M
$-1.2M
Q1 25
$256.6M
$-14.6M
Q4 24
$202.8M
$14.9M
Q3 24
$246.5M
$-9.2M
Q2 24
$159.0M
Free Cash Flow
FFIV
FFIV
GENI
GENI
Q1 26
Q4 25
$149.5M
$69.6M
Q3 25
$191.9M
$-14.2M
Q2 25
$273.7M
$-5.8M
Q1 25
$246.1M
$-16.0M
Q4 24
$194.7M
$11.3M
Q3 24
$240.4M
$-11.6M
Q2 24
$153.1M
FCF Margin
FFIV
FFIV
GENI
GENI
Q1 26
Q4 25
18.2%
13.6%
Q3 25
23.7%
-4.2%
Q2 25
35.1%
-2.7%
Q1 25
33.7%
-13.4%
Q4 24
25.4%
2.7%
Q3 24
32.2%
-4.1%
Q2 24
22.0%
Capex Intensity
FFIV
FFIV
GENI
GENI
Q1 26
Q4 25
1.2%
2.4%
Q3 25
2.0%
2.8%
Q2 25
1.1%
2.1%
Q1 25
1.4%
1.2%
Q4 24
1.1%
0.9%
Q3 24
0.8%
0.9%
Q2 24
0.8%
Cash Conversion
FFIV
FFIV
GENI
GENI
Q1 26
3.55×
Q4 25
0.88×
Q3 25
1.09×
Q2 25
1.49×
Q1 25
1.76×
Q4 24
1.22×
Q3 24
1.49×
Q2 24
1.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons